WIGLEY MICHAEL

CIK 00010546041 companyFRANKLIN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001054604

Recent Transactions

50 trades

Purchase
Echo Therapeutics, Inc.
Common Stock
2005-09-06$1.29/sh+5,000→ 783,047 total
Purchase
Echo Therapeutics, Inc.
Common Stock
2005-09-06$1.29/sh+5,000→ 783,047 total
Purchase
Echo Therapeutics, Inc.
Common Stock
2005-09-06$1.21/sh+5,000→ 783,047 total
Purchase
Echo Therapeutics, Inc.
Common Stock
2005-09-06$1.21/sh+5,000→ 783,047 total
Purchase
Echo Therapeutics, Inc.
Common Stock
2005-09-02$1.29/sh+5,000→ 783,047 total
Purchase
Echo Therapeutics, Inc.
Common Stock
2005-09-02$1.28/sh+3,500→ 783,047 total
Purchase
Echo Therapeutics, Inc.
Common Stock
2005-09-02$1.29/sh+5,000→ 783,047 total
Purchase
Echo Therapeutics, Inc.
Common Stock
2005-09-02$1.28/sh+3,500→ 783,047 total
Purchase
Echo Therapeutics, Inc.
Common Stock
2005-08-31$1.28/sh+1,500→ 764,547 total
Purchase
Echo Therapeutics, Inc.
Common Stock
2005-08-31$1.29/sh+5,000→ 764,547 total
Purchase
Echo Therapeutics, Inc.
Common Stock
2005-08-31$1.28/sh+1,500→ 764,547 total
Purchase
Echo Therapeutics, Inc.
Common Stock
2005-08-31$1.29/sh+5,000→ 764,547 total
Purchase
Echo Therapeutics, Inc.
Common Stock
2005-08-30$1.29/sh+5,000→ 764,547 total
Purchase
Echo Therapeutics, Inc.
Common Stock
2005-08-30$1.29/sh+5,000→ 764,547 total
Award
Echo Therapeutics, Inc.
Director Stock Option (right to buy)
2005-05-24+81,579→ 81,579 total
Award
Echo Therapeutics, Inc.
Director Stock Option (right to buy)
2005-05-24+81,579→ 81,579 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+105,479→ 674,222 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+91,618→ 91,618 total
Conversion
Echo Therapeutics, Inc.
Series A Preferred Stock
2004-05-20−100,000→ 0 total
Conversion
Echo Therapeutics, Inc.
Series A Preferred Stock
2004-05-20−90,000→ 0 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+15,717→ 56,217 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+56,585→ 56,585 total
Conversion
Echo Therapeutics, Inc.
Series A Preferred Stock
2004-05-20−15,000→ 0 total
Conversion
Echo Therapeutics, Inc.
Series A Preferred Stock
2004-05-20−15,000→ 0 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+36,672→ 36,672 total
Conversion
Echo Therapeutics, Inc.
Series A Preferred Stock
2004-05-20−15,000→ 0 total
Conversion
Echo Therapeutics, Inc.
Series A Preferred Stock
2004-05-20−35,000→ 0 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+94,300→ 94,300 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+26,195→ 52,695 total
Conversion
Echo Therapeutics, Inc.
Series A Preferred Stock
2004-05-20−20,000→ 0 total
Conversion
Echo Therapeutics, Inc.
Series A Preferred Stock
2004-05-20−90,000→ 0 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+15,717→ 55,517 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+36,672→ 36,672 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+15,717→ 55,517 total
Conversion
Echo Therapeutics, Inc.
Series A Preferred Stock
2004-05-20−35,000→ 0 total
Conversion
Echo Therapeutics, Inc.
Series A Preferred Stock
2004-05-20−20,000→ 0 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+94,300→ 94,300 total
Conversion
Echo Therapeutics, Inc.
Series A Preferred Stock
2004-05-20−90,000→ 0 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+20,956→ 20,956 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+26,195→ 52,695 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+20,956→ 20,956 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+15,717→ 55,417 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+91,618→ 91,618 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+15,717→ 56,217 total
Conversion
Echo Therapeutics, Inc.
Series A Preferred Stock
2004-05-20−15,000→ 0 total
Conversion
Echo Therapeutics, Inc.
Series A Preferred Stock
2004-05-20−55,000→ 0 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+105,479→ 674,222 total
Conversion
Echo Therapeutics, Inc.
Series A Preferred Stock
2004-05-20−90,000→ 0 total
Conversion
Echo Therapeutics, Inc.
Common Stock
2004-05-20+56,585→ 56,585 total
Conversion
Echo Therapeutics, Inc.
Series A Preferred Stock
2004-05-20−100,000→ 0 total

Companies

Echo Therapeutics, Inc.
Director

Recent Filings

Address

C/O SONTRA MEDICAL CORPORATION 10 FORGE PARKWAY

FRANKLIN, MA, 02038

View on SEC.gov